4.4 Article

Steroid metabolism in chimeric mice with humanized liver

Journal

DRUG TESTING AND ANALYSIS
Volume 1, Issue 11-12, Pages 531-537

Publisher

JOHN WILEY & SONS LTD
DOI: 10.1002/dta.67

Keywords

steroids; metabolism; doping; chimeric mice; urine

Funding

  1. World Anti-Doping Agency (WADA)
  2. Belgian Government via the Interuniversity Attraction Poles Program [P6/36-HEPRO]
  3. Ghent University [BOF 011D3099]
  4. Concerted Action [01G00507]
  5. Research Foundation - Flanders
  6. Spanish Ministerio de Educacion y Ciencia

Ask authors/readers for more resources

Anabolic androgenic steroids are considered to be doping agents and are prohibited in sports. Their metabolism needs to be elucidated to allow for urinary detection by gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS). Steroid metabolism was assessed using uPA(+/+) SCID mice with humanized livers (chimeric mice). This study presents the results of 19-norandrost-4-ene-3,17-dione (19-norAD) administration to these in vivo mice. As in humans, 19-norandrosterone and 19-noretiocholanolone are the major detectable metabolites of 19-norAD in the urine of chimeric mice. A summary is given of the metabolic pathways found in chimeric mice after administration of three model steroid compounds (methandienone, androst-4-ene-3,17-dione and 19-norandrost-4-ene-3,17-dione). From these studies we can conclude that all major metabolic pathways for anabolic steroids in humans are present in the chimeric mouse. It is hoped that, in future, this promising chimeric mouse model might assist the discovery of new and possible longer detectable metabolites of (designer) steroids. Copyright (C) 2009 John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available